{"entity":{"id":"nct07266285","kind":"trial","name":"BTM-3566 in Advanced Solid Tumors","aka":[],"tldr":"A phase 1 trial of BTM-3566 run by Bantam Pharmaceuticals, now recruiting.","summary":"BTM-3566 in Advanced Solid Tumors is a phase 1 interventional study registered as NCT07266285 by Bantam Pharmaceuticals, with 30 participants planned, started 2025-12-10. Conditions recorded: Advanced Solid Tumors. Interventions recorded: BTM-3566.","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT07266285","url":"https://clinicaltrials.gov/study/NCT07266285"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["btm-3566"],"companies":["bantam-pharmaceutical"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07266285","phase":"1","setting":"A Phase 1 Trial of BTM-3566 in Advanced Solid Tumors","sponsor":"Bantam Pharmaceuticals","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07266285/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}],"drug":[{"id":"btm-3566","kind":"drug","name":"BTM-3566","route":"/drugs/btm-3566/"}],"company":[{"id":"bantam-pharmaceutical","kind":"company","name":"Bantam Pharmaceutical","route":"/companies/bantam-pharmaceutical/"}]}}